Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 10,000 shares at $6.11 ($61K) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Open-market sale of $61k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |
| EBS | SELL | 2024-05-23 | $6K | — | Filing → |